mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |